Primary small cell neuroendocrine carcinoma of the larynx. Two case reports.
Two cases of primary small cell neuroendocrine carcinoma of the larynx (SCNLC) are presented. One patient is alive at 5 years without evidence of disease, after the combined therapy (surgery, radiotherapy and chemotherapy), the either treated without adjuvant chemotherapy died at 22 months because of lung and liver metastases.
Reinfuss
M
M
Center of Oncology, Maria Sklodowska-Curie Memorial Institute, Kraków, Poland.
Kowalska
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018278:Carcinoma, Neuroendocrine / Q000473:pathology / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology / Q000628:therapy*; D007825:Laryngectomy; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage